S. Villà

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations

Medicine, Oncology, Radiation Oncology +17

Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study

Martin Köcher, Riccardo Soffietti, Ufuk Abacıoğlu et al. · Journal of Clinical Oncology · 2010 · 2K citations · Full text

Medicine, Oncology, Surgery +17

A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results

Riccardo Soffietti, Martin Köcher, Ufuk Abacıoğlu et al. · Journal of Clinical Oncology · 2012 · 645 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial

René-Olivier Mirimanoff, Thierry Gorlia, Warren Mason et al. · Journal of Clinical Oncology · 2006 · 508 citations

Medicine, Oncology, Radiation Oncology +17

High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial

A. Zapatero, A. Guerrero, Xavier Maldonado et al. · The Lancet Oncology · 2015 · 300 citations

Medicine, Oncology, Radiation Oncology +17